Live from the NIH registry
Studies recruiting near Hagerstown right now
Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Klein and Associates — Hagerstown, Maryland (0.1 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Macular Telangiectasia Type 2 (MacTel)
Phase 4
Interventional 234 participants sought
Cumberland Valley Retina Consultants — Frederick, Maryland (22.8 mi)
· Sponsor: Neurotech Pharmaceuticals
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
FMH James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: National Cancer Institute (NCI)
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Breast Cancer
N/A
Observational 1,800 participants sought
Meritus Center for Clinical Research — Hagerstown, Maryland (0.1 mi)
· Sponsor: Exact Sciences Corporation
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Klein & Associates, M.D., P.A. — Hagerstown, Maryland (0.1 mi)
· Sponsor: Takeda
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
Mid Atlantic Retina Specialists — Hagerstown, Maryland (0.1 mi)
· Sponsor: Amgen
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
FMH James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Klein And Associates M D P A — Hagerstown, Maryland (0.1 mi)
· Sponsor: Janssen Research & Development, LLC
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
Stomatitis
Phase 4
Interventional 100 participants sought
Research Site — Frederick, Maryland (22.8 mi)
· Sponsor: AstraZeneca
ConsideRAte Study - Splenic Stimulation for RA
Rheumatoid Arthritis
N/A
Interventional 28 participants sought
The Osteoporosis & Clinical Trials Center — Hagerstown, Maryland (0.1 mi)
· Sponsor: Galvani Bioelectronics
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
Brief Motivational Interviewing +/- Mindfulness Training for Adolescent Alcohol Use in Pediatric Primary Care
Adolescent Alcohol Use
N/A
Interventional 1,500 participants sought
Johns Hopkins Community Physicians, Hagerstown — Hagerstown, Maryland (0.1 mi)
· Sponsor: Johns Hopkins University
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
Frederick Health Hospital - James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Janssen Research & Development, LLC
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Mid Atlantic Retina Specialists — Hagerstown, Maryland (0.1 mi)
· Sponsor: EyeBiotech Ltd.
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Phase 2
Interventional 461 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: DalCor Pharmaceuticals
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Macular Edema
Phase 2
Interventional 300 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: Boehringer Ingelheim
Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
HIV Testing, HEPATITIS C (HCV)
N/A
Observational 200 participants sought
WVU Department of Family Medicine - Eastern Division — Harpers Ferry, West Virginia (21.8 mi)
· Sponsor: West Virginia University
A Study in Adults With Geographic Atrophy
Geographic Atrophy
Phase 2
Interventional 300 participants sought
Cumberland Valley Retina Consultants,P.C. — Hagerstown, Maryland (0.1 mi)
· Sponsor: Sitala Bio LTD
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Lung Non-Small Cell Carcinoma
Phase 2
Interventional 88 participants sought
WellSpan Medical Oncology and Hematology — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: NRG Oncology
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 700 participants sought
James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Eli Lilly and Company